V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20212394 | 20128769 | 1.79 | 107.2 | Neo-adjuvant (N) | 2016-04-08 | 2017-04-15 | null | N | N | NIVOLUMAB | 101367110 |
| 20212395 | 20128770 | 1.75 | 51 | Palliative (P) | 2018-02-13 | 2018-03-07 | CARBOPLATIN + ETOPOSIDE | N | N | CARBOPLATIN + ETOPOSIDE | 100357021 |
| 20212401 | 20128772 | 1.71 | 82.8 | null | null | 2017-01-19 | Panitumumab | 02 | null | PANITUMUMAB | 100495119 |
| 20212406 | 20128775 | 1.71 | 44.7 | Curative (C) | 2019-09-17 | 2019-12-20 | Carboplatin + Etoposide IV 3 day | null | N | CARBOPLATIN + ETOPOSIDE | 100103610 |
| 20212407 | 20128776 | 1.77 | 45.2 | null | 2017-12-12 | 2017-12-26 | null | N | null | NIVOLUMAB | 100718415 |
| 20212413 | 20128778 | 1.76 | 74.6 | Adjuvant (A) | 2017-09-04 | 2017-10-03 | NIVOLUMAB | null | N | NIVOLUMAB | 100616920 |
| 20212416 | 20128779 | 1.59 | 114.8 | Palliative (P) | null | 2016-05-27 | CISPLATIN + FLUOROURACIL | N | N | CISPLATIN + FLUOROURACIL | 101804402 |
| 20212420 | 20128780 | 1.59 | 93.5 | Palliative (P) | 2021-01-17 | 2021-01-19 | Panitumumab | N | null | PANITUMUMAB | 100936002 |
| 20212421 | 20128781 | 1.66 | null | Neo-adjuvant (N) | 2016-07-16 | 2016-07-31 | null | 02 | N | PANITUMUMAB | 101243648 |
| 20212422 | 20128782 | 1.82 | null | Palliative (P) | 2020-09-21 | 2020-10-16 | CARBOPLATIN + ETOPOSIDE | 02 | null | CARBOPLATIN + ETOPOSIDE | 101796717 |
| 20212425 | 20128783 | 1.72 | null | Palliative (P) | 2019-07-27 | 2019-07-27 | ECX | N | null | ECX | 101778197 |
| 20212426 | 20128784 | 1.5 | 50 | Neo-adjuvant (N) | 2019-01-25 | 2019-03-05 | null | N | N | PANITUMUMAB | 100173247 |
| 20212427 | 20128785 | 1.84 | 44.7 | Curative (C) | 2018-11-28 | 2018-11-28 | null | 02 | null | PANITUMUMAB | 101165088 |
| 20212428 | 20128786 | null | null | Curative (C) | 2018-02-27 | 2018-03-01 | null | 02 | null | CARBOPLATIN + ETOPOSIDE | 101443647 |
| 20212431 | 20128787 | 1.59 | null | Curative (C) | 2018-05-17 | 2018-05-30 | null | 02 | N | NIVOLUMAB | 101858865 |
| 20212432 | 20128788 | 1.73 | 79.5 | Palliative (P) | 2019-06-15 | 2019-06-17 | Carboplatin + Etoposide iv&po | null | N | CARBOPLATIN + ETOPOSIDE | 101582638 |
| 20212433 | 20128789 | 1.72 | null | Palliative (P) | 2018-10-04 | 2018-10-04 | ECX | 2 | N | ECX | 100576849 |
| 20212434 | 20128790 | 1.76 | 84 | Palliative (P) | 2016-09-29 | 2016-09-29 | Panitumumab | null | N | PANITUMUMAB | 101057729 |
| 20212436 | 20128792 | 1.7 | 51 | Palliative (P) | 2017-06-14 | 2017-07-10 | null | N | N | ECX | 101203375 |
| 20212440 | 20128794 | 1.47 | 107.6 | null | 2019-04-10 | 2019-04-22 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 100605056 |
| 20212441 | 20128795 | 1.53 | 65.6 | null | 2018-09-02 | 2018-09-13 | NIVOLUMAB | 2 | null | NIVOLUMAB | 100539263 |
| 20212443 | 20128796 | 1.88 | 59.1 | Neo-adjuvant (N) | 2020-12-22 | 2020-12-23 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100415575 |
| 20212444 | 20128797 | 1.77 | null | Neo-adjuvant (N) | 2016-01-25 | 2016-11-30 | Cisplatin + Fluorouracil + RT 5day | 02 | N | CISPLATIN + FLUOROURACIL | 100919051 |
| 20212446 | 20128798 | 1.76 | null | null | 2016-06-20 | 2016-06-28 | null | null | Y | PANITUMUMAB | 101208903 |
| 20212447 | 20128799 | 1.71 | 103.1 | null | null | 2017-03-31 | null | N | N | ECX | 100124259 |
| 20212448 | 20128800 | 1.67 | 131.75 | null | 2018-03-05 | 2018-03-26 | null | N | N | CISPLATIN + FLUOROURACIL | 101317081 |
| 20212449 | 20128801 | 1.75 | 54.6 | Neo-adjuvant (N) | 2021-01-24 | 2021-07-08 | Panitumumab | N | N | PANITUMUMAB | 101558204 |
| 20212451 | 20128802 | null | 77.8 | Curative (C) | 2018-03-13 | 2018-03-27 | ECX | 02 | null | ECX | 100528108 |
| 20212452 | 20128803 | 1.77 | 70.42 | Adjuvant (A) | 2017-12-20 | 2018-07-09 | ECX | 2 | null | ECX | 100102989 |
| 20212457 | 20128804 | 1.53 | 45 | Neo-adjuvant (N) | 2016-05-05 | 2016-12-21 | null | 02 | N | NIVOLUMAB | 101095116 |
| 20212462 | 20128805 | 1.73 | 68 | null | 2020-04-27 | 2020-05-17 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101488151 |
| 20212463 | 20128806 | 1.73 | null | Adjuvant (A) | 2016-09-08 | 2016-09-08 | NIVOLUMAB | 2 | N | NIVOLUMAB | 101835708 |
| 20212464 | 20128807 | 1.72 | 97.6 | Palliative (P) | 2017-11-23 | 2017-11-27 | Panitumumab | 02 | N | PANITUMUMAB | 101365642 |
| 20212466 | 20128808 | 1.72 | 67.3 | null | 2017-09-03 | 2017-09-06 | Panitumumab | 02 | N | PANITUMUMAB | 100611337 |
| 20212467 | 20128809 | 1.65 | 67 | Curative (C) | 2019-05-30 | 2019-06-14 | null | 02 | null | PANITUMUMAB | 101797961 |
| 20212471 | 20128811 | 1.7 | 57.1 | Neo-adjuvant (N) | 2018-09-30 | 2018-10-07 | Panitumumab | 02 | N | PANITUMUMAB | 101049656 |
| 20212477 | 20128812 | 1.78 | 51.9 | Curative (C) | 2017-04-10 | 2017-04-14 | null | 02 | N | CISPLATIN + FLUOROURACIL | 101616829 |
| 20212478 | 20128813 | 1.61 | null | Curative (C) | 2017-07-15 | 2017-07-17 | null | 02 | n | CARBOPLATIN + ETOPOSIDE | 100498306 |
| 20212479 | 20128814 | 1.72 | null | null | 2019-02-15 | 2019-02-18 | null | 02 | null | ECX | 101552030 |
| 20212481 | 20128815 | 1.58 | 97 | Neo-adjuvant (N) | null | 2017-06-07 | Panitumumab | 02 | N | PANITUMUMAB | 101657011 |
| 20212482 | 20128816 | 1.75 | 84.3 | Neo-adjuvant (N) | 2019-07-15 | 2019-07-23 | Panitumumab | 02 | N | PANITUMUMAB | 101059947 |
| 20212488 | 20128817 | 1.75 | null | Curative (C) | 2018-09-08 | 2018-09-16 | null | 02 | N | ECX | 100362655 |
| 20212489 | 20128818 | 1.76 | 43 | Palliative (P) | 2018-12-22 | 2019-02-03 | Panitumumab | 02 | N | PANITUMUMAB | 101432382 |
| 20212498 | 20128820 | 1.64 | 92.1 | null | 2018-10-05 | 2018-10-10 | Carboplatin + Etoposide iv&po | 02 | Y | CARBOPLATIN + ETOPOSIDE | 101688803 |
| 20212499 | 20128821 | null | 83 | null | 2019-06-21 | 2019-09-17 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100633935 |
| 20212501 | 20128822 | null | null | Palliative (P) | 2017-02-02 | 2017-02-03 | ECX | 02 | N | ECX | 101162966 |
| 20212510 | 20128823 | 1.81 | 74.8 | Palliative (P) | 2019-03-27 | 2019-04-19 | Panitumumab | 02 | N | PANITUMUMAB | 100454608 |
| 20212512 | 20128824 | 1.56 | null | Palliative (P) | null | 2020-10-14 | null | null | N | PANITUMUMAB | 101638396 |
| 20212513 | 20128825 | 1.77 | 96.8 | Palliative (P) | 2018-12-03 | 2018-12-04 | null | N | N | ECX | 100550620 |
| 20212515 | 20128826 | 1.65 | 48.1 | Disease modification (D) | 2017-02-08 | 2017-02-15 | null | N | null | PANITUMUMAB | 100394523 |